Results 251 to 260 of about 217,331 (294)

When is A Kidney Biopsy Indicated During the Treatment of Brain Cancer? [PDF]

Eur J Case Rep Intern Med
Oliveira-Silva C, Viana J, Coelho C, Silva R, Falcão L, Rocha J, Ribeiro B.   +6 more
europepmc   +1 more source

Remission of nephrotic range proteinuria in type I diabetes

, 1994
Lee A. Hebert, Raymond P. Bain, Dante Verme, Daniel Cattran, Frederick C. Whittier, Nathan Tolchin, Richard D. Rohde, Edmund J. Lewis, Edmund J. Lewis, Richard Rohde, Mark T. Nemcek, Lawrence G. Hunsicker, Raymond P. Bain, John M. Lachin, Samuel W. Greenhouse, DA. Verme, T.R. Turlington, P.K. Burrows, Jay B. Wish, John P. Sheehan, Marc A. Pohl, Tomás Berl, G. Santiago, J. Lemann, Samuel S. Blumenthal, Barbara A. Bresnahan, L Hebert, N. Stanley Nahman, Stanley Goldfarb, Sidney Kobrin, Roger A. Rodby, Stephen Lietz, Daiva Valaitis, A. Levey and M. McLaughlin, Mathew Williams, Janet B. McGill, F. Whittier, Daniel C. Cattran, Jessie E. Hano, Douglas Maxwell, Jerome G. Porush, Samuel Spitalewitz, K. Shapiro, Sharon G. Adler, Nathan Tolchin, Wendy E. Hoy, Robert Bernstein, Laura P. Svetkey, Z. Sharon, B Rosenbaum, Jonathan Anolik, H. Tidesley, Caroline Joyce, Julia A. Breyer   +53 more
openalex   +1 more source

Sulphonylurea efficacy and end‐organ outcomes in the management of HNF4A‐MODY

Diabetic Medicine, EarlyView.
Abstract Aims Sulphonylurea agents are typically used to treat HNF4A‐MODY based on the pharmacogenetic aetiology of the condition, although limited evidence exists in the literature for this practice. The aims of this study were to determine the efficacy of sulphonylurea drugs during follow‐up, to explore the role of adjunctive therapies in this cohort
M. T. Crowley, N. Ng, E. Goulden, B. Sanchez‐Lechuga, S. Ludgate, M. Burke, K. Colclough, S. Bacon, M. M. Byrne   +8 more
wiley   +1 more source

Hypertensive Nephrosclerosis: Pathological Changes and Overlap with Diabetic Nephropathy. [PDF]

Cureus
Qasim H, Ktaifan M, Awawdeh A, Khattab K, Leoni MLG, Varrassi G.   +5 more
europepmc   +1 more source

Eplerenone improves kidney function and cardiac performance in obese male mice

Diabetic Medicine, EarlyView.
Abstract Aims Renin‐angiotensin‐aldosterone system (RAAS) activation mediates obesity‐associated cardiorenal dysfunction. Due to an incomplete understanding of the molecular mechanisms, the clinical use of RAAS antagonism in obesity‐associated cardiometabolic complications remains uncertain.
Ayman K. Banah, Bingxue Qi, Ryan Koh, Alexander Lawlor, Tianzhen Wang, Vishal Musale, Joanne Mains, Colin E. Murdoch, Li Kang   +8 more
wiley   +1 more source

Relationship between Urine Protein-To-Creatinine Ratio and Leukocyte Esterase in Canine Urine Samples. [PDF]

Vet Med Sci
Liao CY, Cheng TL, Lai CH.
europepmc   +1 more source

A 7‐year prospective analysis of sustained benefits of multicomponent risk assessment and data‐driven care in patients with type 2 diabetes: The Malaysian JADE Program

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aim We evaluated the sustained effects of multicomponent risk assessment and data‐driven care augmented by the web‐based Joint Asia Diabetes Evaluation (JADE) Platform with a built‐in template to guide comprehensive assessment (CA) for risk stratification on top of usual care in patients with type 2 diabetes (T2D) from Malaysia.
Jia‐Xin Hoo, Ya‐Feng Yang, Eric S. H. Lau, Luqman Ibrahim, Shireene R. Vethakkan, Jeyakantha Ratnasingam, Siew‐Pheng Chan, Sharmila S. Paramasivam, Yook‐Chin Chia, Alexander T. B. Tan, Andrea O. Y. Luk, Sanjay Rampal, Juliana C. N. Chan, Lee‐Ling Lim   +13 more
wiley   +1 more source

Spectrum and clinical profile of glomerular diseases in a Nepalese cohort, a tertiary care center study: focus on comparing IgA nephropathy with other primary glomerulonephritis. [PDF]

BMC Nephrol
Saud KP, Shah DS, Bhurtyal N, Bidari SK, Jaishi S, Timilsaina MK.   +5 more
europepmc   +1 more source

Metabolic bariatric surgery is associated with reduced adverse hepatic and extrahepatic outcomes, and lower all‐cause mortality, in patients with steatotic liver disease

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aim Metabolic bariatric surgery (MBS) improves histological endpoints in steatotic liver disease (SLD), but data on longer‐term clinical outcomes in this population are scarce. Here, we assessed the impact of MBS on hepatic and extrahepatic morbidity and mortality in individuals with SLD.
Weronika Stupalkowska, Alexander Henney, Eric G. Sheu, Uazman Alam, Daniel J. Cuthbertson   +4 more
wiley   +1 more source

Clinical Predictors of Underlying Histologic Activity in Patients with Lupus Nephritis: A Focus on Urinary Soluble CD163. [PDF]

J Clin Med
Obrișcă B, Vrabie A, Lujinschi Ș, Jurubiță R, Mocanu V, Berechet A, Sorohan B, Andronesi A, Lupușoru G, Achim C, Micu G, Manda D, Poalelungi C, Caceaune N, Dima S, Ismail G.   +15 more
europepmc   +1 more source